Fas ligand
Fas ligand (also known as FasL, CD95L, or CD178) is a type-1 transmembrane protein that belongs to the tumor necrosis factor (TNF) family. It binds with the Fas receptor (CD95) to induce apoptosis, a process of programmed cell death. Fas ligand plays a crucial role in the regulation of the immune system and the progression of cancer.
Structure
Fas ligand is a type-II transmembrane protein, which means it has an extracellular C-terminal domain and a cytoplasmic N-terminal domain. The extracellular domain of Fas ligand is what interacts with the Fas receptor. The cytoplasmic domain is not required for apoptosis induction.
Function
The primary function of Fas ligand is to bind to the Fas receptor and initiate a series of events that lead to apoptosis. This process is critical for the regulation of the immune system. It helps to maintain immune homeostasis and prevent autoimmune diseases by killing off excess or harmful cells.
Fas ligand is also involved in immune privilege, a state in which certain body sites are able to tolerate the introduction of antigens without eliciting an inflammatory immune response. This is achieved by Fas ligand-mediated apoptosis of invading immune cells.
Role in Disease
Alterations in the Fas ligand/Fas receptor system can lead to various diseases. For example, mutations in the Fas ligand or Fas receptor can cause autoimmune lymphoproliferative syndrome (ALPS), a rare disorder characterized by non-malignant lymphoproliferation, autoimmunity, and increased risk of lymphoma.
In cancer, Fas ligand expression can be a double-edged sword. On one hand, cancer cells can use Fas ligand to kill attacking immune cells and evade the immune response. On the other hand, therapies that enhance Fas ligand expression can be used to kill cancer cells.
See Also
- Apoptosis
- Fas receptor
- Tumor necrosis factor (TNF) family
- Autoimmune lymphoproliferative syndrome (ALPS)
- Immune privilege
References
<references />
This article is a immunology stub. You can help WikiMD by expanding it!
Fas ligand
-
Fas ligand
-
Fas signaling
-
Signal transduction pathways
Ad. Transform your life with W8MD's Budget GLP-1 injections from $29.99


W8MD offers a medical weight loss programs including NYC medical weight loss and Philadelphia medical weight loss offering:
- Budget GLP1 shots (generic and brand names) such as
- Learn more: Budget GLP1 weight loss injections NYC & Philadelphia GLP1 weight loss shots
- Most insurances accepted
- Budget GLP1 weight loss injections such as Semaglutide starting from $29.99/week and $45.00/week (Tirzepatide) with insurance.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our:
- Call 718-946-5500 for NYC or 215-676-2334 for Philadelphia
- Tags:
GLP1 weight loss doctor NYC, Zepbound NYC, Budget GLP1 weight loss injections, Philadelphia medical weight loss, Wegovy NYC, Brooklyn weight loss, Wegovy NYC, Budget GLP1 shots NYC
Linkedin_Shiny_Icon
YouTube_icon_(2011-2013)
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
